AC
PMN icon

Armistice Capital’s ProMIS Neurosciences PMN Stock Holding History

Armistice Capital’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-118,981
Closed -$1.26M – 465
2025
Q3 		$1.26M Buy
118,981
+33,465
+39% +$463K 0.02% 159
2025
Q2 		$1.03M Sell
85,516
-7,877
-8% -$107K 0.02% 148
2025
Q1 		$1.62M Sell
93,393
-7,006
-7% -$149K 0.02% 155
2024
Q4 		$2.38M Sell
100,399
-6,401
-6% -$159K 0.03% 148
2024
Q3 		$3.34M Buy
+106,800
New +$3.99M 0.05% 141

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
DEM
Disciplined Equity Management Neptune Beach, Florida $199M AUM 20.69% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Armistice Capital's PMN Position: Q4 2025 in Review

Armistice Capital sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 118,981 shares — an estimated $1.26M sold.

Armistice Capital first reported a position in PMN in Q3 2024 and held it in 5 quarters. The position peaked at $3.34M in Q3 2024. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

  • Armistice Capital reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
  • Armistice Capital sold 118,981 ProMIS Neurosciences shares in Q4 2025, an estimated $1.26M.
  • Armistice Capital first reported a position in ProMIS Neurosciences in Q3 2024 and held it in 5 quarters.
  • Armistice Capital's ProMIS Neurosciences position peaked at $3.34M in Q3 2024.
  • 9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.